At a glance
- Originator Unknown
- Developer Zenyaku Kogyo
- Class Cardiotonics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 30 Aug 1995 Discontinued-unspecified phase for Heart Failure